B · Normal
On October 29th, Bristol-Myers Squibb's adjusted earnings per share in the third quarter were US$1.35, with an estimate of US$1.12; revenue was US$13.07 billion, with an estimate of US$12.72 billion; Eliquis revenue was US$4.69 billion, with an estimate of US$4.63 billion.
U.S. stock trends 🕐 2026-10-29 19:07

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet